Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols
- 22 February 2022
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 62 (4) , 863-870
Abstract
Allo-antibodies produced by K-negative pregnant women against a fetal K antigen from the Kell blood group system may cause hemolytic disease of the fetus and newborn (HDFN). Predicting the fetal K antigen using noninvasive prenatal testing (NIPT) is important for decisions concerning management of pregnancies. Digital and droplet digital PCR techniques permit the detection of fetal single nucleotide variant with a higher specificity and sensitivity than real-time polymerase chain reaction (PCR). Aim The aim was to evaluate and compare protocols for fetal KEL*01.01 genotyping using different assays and digital PCR platforms. Methods DNA isolated from 59 pregnant women (9–39 weeks of gestation, 49 with anti-K) was tested using home-made and custom-ordered KEL*01.01/KEL*02 assays with Droplet Digital™ and QuantStudio™3D. The results were compared with fetal/neonatal genotypes/phenotypes. Results Fetal KEL*01.01 results using all tested protocols were concordant with fetal/neonatal KEL*01.01 genotypes/phenotypes. None of the tested combinations of assays or digital PCR platforms gave false KEL*01.01-negative results, but inconclusive KEL*01.01 reads were observed in all tested protocols. For 36 cases compared using two digital PCR platforms and assays, there were not statistically significant differences in a level of fetal KEL*01.01 fraction (p < .72). Conclusion Independent of the applied dPCR and ddPCR platforms and KEL*01.01 assays, prediction of the fetal KEL*01.01 is highly reliable. Before implementation in routine practice further validation of the KEL*01.01 protocol with a larger group of pregnant women should be performed.Keywords
This publication has 18 references indexed in Scilit:
- An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigensAmerican Journal of Reproductive Immunology, 2016
- Performance of Droplet Digital PCR in Non-Invasive Fetal RHD Genotyping - Comparison with a Routine Real-Time PCR Based ApproachPLOS ONE, 2015
- 14 Years of Polish Experience in Non-Invasive Prenatal Blood Group DiagnosisTransfusion Medicine and Hemotherapy, 2015
- Fetal Sex and RHD Genotyping with Digital PCR Demonstrates Greater Sensitivity than Real-time PCRClinical Chemistry, 2015
- Noninvasive fetal genotyping of human platelet antigen‐1a using targeted massively parallel sequencingTransfusion, 2015
- Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status2015
- Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allelePrenatal Diagnosis, 2013
- Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experienceBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal DNA in Maternal PlasmaClinical Chemistry, 2008
- Presence of fetal DNA in maternal plasma and serumThe Lancet, 1997